YAbS

YAbS

Database for
Therapeutic Antibodies

Home
Database
Tutorial
Statistics
Contact Us
Login

Home
Database
Tutorial
Statistics
Contact Us
Login

Molecule name (INN, drug code)

Molecular Characteristics

General Molecular Category^*

Target antigen(s) Click here to view the target list

Format, general category

All
Appended Ig
Appended Ig conjugate
Appended Ig fusion
Fragment
Fragment conjugate
Fragment fusion
Fragment-Fc
Fragment-Fc conjugate
Fragment-Fc fusion
Full length Ab
Full length Ab conjugate
Full length Ab fusion
TBD

Isotype (Fc)

All
IgE
IgG1
IgG1/2
IgG1/3
IgG1/4
IgG2
IgG2/4
IgG2a
IgG2a, IgG2b
IgG2a/b
IgG2b
IgG3
IgG4
IgM
None
TBD

Light chain isotype

All
kappa
kappa, lambda
kappa/lambda
lambda
None
TBD
Vlambda-Ckappa

mAb sequence source

All
mAb - source TBD
mAb chimeric
mAb chimeric/human
mAb chimeric/humanized
mAb deimmunized
mAb human
mAb human, humanized
mAb humanized
mAb humanized/human
mAb murine
mAb murine/rat
mAb primatized

Clinical development

General development status category

All
Approved
Clinical
Emergency use
IND
No development reported
Preclinical
Regulatory review
Terminated
Withdrawn

Most advanced stage of development (global)

Approved
- All
- Approved Argentina, Cuba
- Approved China
- Approved China, India, Cuba
- Approved EU
- Approved EU, Australia, South Korea
- Approved EU, China
- Approved EU, China, UK
- Approved EU, Japan, Australia
- Approved EU, Japan, Australia, UK
- Approved EU, UK, Australia
- Approved EU, US
- Approved EU, US, Australia
- Approved EU, US, Australia, Canada
- Approved EU, US, Australia, UK
- Approved EU, US, Australia, UK, Switzerland
- Approved EU, US, Canada
- Approved EU, US, Canada, UK, Australia
- Approved EU, US, China, Australia, Canada, UK
- Approved EU, US, China, Australia, UK
- Approved EU, US, China, Switzerland, UK
- Approved EU, US, China, UK
- Approved EU, US, Japan
- Approved EU, US, Japan, Australia
- Approved EU, US, Japan, Australia, Canada
- Approved EU, US, Japan, Australia, Canada, Switzerland
- Approved EU, US, Japan, Australia, Canada, UK
- Approved EU, US, Japan, Australia, Russia
- Approved EU, US, Japan, Australia, UK
- Approved EU, US, Japan, Australia, UK, Canada
- Approved EU, US, Japan, Canada
- Approved EU, US, Japan, China
- Approved EU, US, Japan, China, Australia
- Approved EU, US, Japan, China, Australia, Canada
- Approved EU, US, Japan, China, Australia, Russia
- Approved EU, US, Japan, China, Canada, UK
- Approved EU, US, Japan, UK
- Approved India
- Approved Japan
- Approved Russia
- Approved US
- Approved US, Australia
- Approved US, Canada, UK
- Approved US, China
- Approved US, Japan
- Approved US, Japan, China, UK
Clinical
- All
- Phase 1
- Phase 1/2
- Phase 1/3
- Phase 2
- Phase 2 pivotal
- Phase 2/3
- Phase 3
Emergency use
- All
- Emergency use authorization
IND
- All
- IND
Preclinical
- All
- Preclinical
Regulatory review
- All
- Regulatory review China
- Regulatory review EU
- Regulatory review EU, Japan
- Regulatory review EU, US
- Regulatory review EU, US, Japan, China
- Regulatory review EU, US, Japan, China, UK
- Regulatory review Japan
- Regulatory review US
Terminated
- All
- Terminated at Phase 1
- Terminated at Phase 1/2
- Terminated at Phase 2
- Terminated at Phase 2/3
- Terminated at Phase 3
- Terminated at preclinical
- Terminated at regulatory review
- Terminated at regulatory review
- Withdrawn after Emergency use authorization
Withdrawn
- All
- Withdrawn

Choose column and search by date

Primary therapeutic area

All
Cancer
Cancer, Immune-mediated / inflammatory disorders
Cancer, Ophthalmic disorders
Cardiovascular / hemostasis disorders
Immune-mediated / inflammatory disorders
Immune-mediated / inflammatory disorders, Metabolic disorders
Infectious diseases
Metabolic disorders
Muscular disorders
Neurological disorders
Ophthalmic disorders
Other - Contraception
Other - Endocrine
Other - Infertility
Other - Intoxication
Other - Kidney disease
Respiratory diseases
Skeletal disorders
Undisclosed

Location of the company

Asia
- All
- China
- India
- Japan
- Republic of Korea
- Singapore
- Taiwan
Australia
- All
- Australia
Europe
- All
- Austria
- Belgium
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Ireland
- Italy
- Netherlands
- Norway
- Poland
- Russia
- Slovakia
- Spain
- Sweden
- Switzerland
- United Kingdom
Middle East
- All
- Iraq
- Israel
North America
- All
- British Virgin Islands
- Canada
- Republic of Cuba
- United States of America

Free Text Search (search any word in any column)

Click to retrieve records

Reset filters

ℹ

The default selected options display the complete data. Click this button to reset to default.

antibody-society

For queries related to the data, please contact:

The Antibody Society: info@antibodysociety.org

Follow us online

antibody-society

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.